3 ms·
Your note about FDA approvals rings true. It can take a very very long time for things to progress to the stage where they're available for sale - particularly
by uptown 15y ago
Your note about FDA approvals rings true. It can take a very very long time for things to progress to the stage where they're available for sale - particularly when it comes to the medical industry. I've been watching a company that's been able to dramatically speed up the detection of things like Tuberculosis (from 21 days to 4 days), E.Coli (from up to 24 hours down to 4 hours), MRSA (up to 24 hours down to 6 hours), etc. ... and they've made what I consider to be remarkable advancements. Yet they haven't yet received the FDA approval necessary to achieve wider adoption of their technology.
http://nanologix.com/test_results.html http://nanologix.com/test_results.html
http://www.technologyreview.com/biomedicine/38404/ http://www.technologyreview.com/biomedicine/38404/
To get silicon valley, or other investors to see the opportunity to back these types of ventures the approval process needs to be streamlined and prioritized in a way that accelerates the time-to-market for technologies that stand to benefit society on the whole.
- VladRussian 15y agoit isn't only FDA per.se. The financial aspects of biomedical R&D is very peculiar. Different time - first half of 199x, different country - recently post-Soviet Russia, different scale of money ... i was involved in the project to secure financing (high tens of thousands of dollars, the project would have become profitable at the 3rd, possibly 2nd year - too long of a shot in the environment where trading in metals, vodka or electronics would bring 50-100% scale profits on the first turnaround, ie. on weeks, rare few months, time scale) for productization of some wonderful technology developed by a leading brain science institution. Well, we failed. These days, with all the supposed and expected high/bio-tech boom and the marvelous advancements just around the corner, we see biotech layoffs, and a couple of PhD degreed with years of experience biomedical professionals i personally know here in the Valley can't get a job even at half what i'm making in the software. One of the reasons of such a state is that financing of the industry requires bigger scale, amount- and time-wise, of money, and thus is coming from banks and other institutions who have significantly decreased imnvestments following 2008. Talking about stimulus and the dirty cheap Federal money the banks have access to - it just isn't trickling down as lazily pumping the money though treasuries and QEs is much more safe way to profit from the money.